Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2005
Microevolution and mega-icebergs in the Antarctic
L D Shepherd, C D Millar, G Ballard, et al.
The Journal of Pediatrics
|
August 10, 2000
Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: A family study
E P Treacy, D M Lambert, R Barnes, et al.
British Journal of Pharmacology
|
June 15, 2007
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
V C J Wallace, A R Segerdahl, D M Lambert, et al.
Journal of Virological Methods
|
October 1, 1985
A simple method for increased recovery of purified paramyxovirus virions
S L Wechsler, D M Lambert, M S Galinski, et al.
Biochimica Et Biophysica Acta
|
October 16, 1999
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors
D M Lambert, F G DiPaolo, P Sonveaux, et al.
Antiviral Research
|
August 1, 1993
Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection
D M Lambert, H Bartus, A V Fernandez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 1996
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
D M Lambert, S Barney, A L Lambert, et al.
Biochemistry
|
August 7, 1992
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays
G B Dreyer, D M Lambert, T D Meek, et al.
Biochemistry
|
October 4, 1994
An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis
S S Abdel-Meguid, B W Metcalf, T J Carr, et al.
Nature
|
January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
T D Meek, D M Lambert, G B Dreyer, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2005
Microevolution and mega-icebergs in the Antarctic
L D Shepherd, C D Millar, G Ballard, et al.
The Journal of Pediatrics
|
August 10, 2000
Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: A family study
E P Treacy, D M Lambert, R Barnes, et al.
British Journal of Pharmacology
|
June 15, 2007
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
V C J Wallace, A R Segerdahl, D M Lambert, et al.
Journal of Virological Methods
|
October 1, 1985
A simple method for increased recovery of purified paramyxovirus virions
S L Wechsler, D M Lambert, M S Galinski, et al.
Biochimica Et Biophysica Acta
|
October 16, 1999
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors
D M Lambert, F G DiPaolo, P Sonveaux, et al.
Antiviral Research
|
August 1, 1993
Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection
D M Lambert, H Bartus, A V Fernandez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 1996
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
D M Lambert, S Barney, A L Lambert, et al.
Biochemistry
|
August 7, 1992
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays
G B Dreyer, D M Lambert, T D Meek, et al.
Biochemistry
|
October 4, 1994
An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis
S S Abdel-Meguid, B W Metcalf, T J Carr, et al.
Nature
|
January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
T D Meek, D M Lambert, G B Dreyer, et al.
Page
of 10